Monitoring disease activity by intestinal ultrasound predicts biologic treatment persistence in patients with Inflammatory Bowel Disease

被引：0
|
作者：
Ilvemark, J. Fremberg [1 ]
Christensen, K. R. [1 ]
Steenholdt, C. [1 ]
Brynskov, J. [1 ]
Attauabi, M. [1 ]
Dahl, E. [1 ]
Bjerrum, J. W. [1 ]
Seidelin, J. B. [1 ]
机构：
[1] Univ Copenhagen, Dept Gastroenterol & Hepatol, Herlev Hosp, Copenhagen, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP07
引用
收藏
页码：I83 / I84
页数：2
相关论文
共 50 条
  • [21] Bedside Intestinal Ultrasound Predicts Disease Severity and the Disease Distribution of Pediatric Patients With Inflammatory Bowel Disease: A Pilot Cross-sectional Study
    Chavannes, Mallory
    Hart, Lara
    Rezvan, Panteha Hayati
    Dillman, Jonathan R.
    Polk, D. Brent
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (03) : 402 - 409
  • [22] Why do we need to improve monitoring of patients with inflammatory bowel disease (IBD) on biologic treatment?
    Egan, Ciara
    Doherty, Glen A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (09) : 907 - 918
  • [23] The Treatment of Pediatric Inflammatory Bowel Disease with Biologic Therapies
    Conrad M.A.
    Kelsen J.R.
    Current Gastroenterology Reports, 2020, 22 (8)
  • [24] Adherence to subcutaneous biologic treatment for inflammatory bowel disease
    Ramos, Laura
    Ramos-Rodriguez, Javier
    De La Barreda, Raquel
    Gutierrez-Nicolas, Fernando
    Carrillo-Palau, Marta
    Alonso-Abreu, Inmaculada
    Nazco-Casariego, Julia
    Quintero, Enrique
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (05): : 335 - 341
  • [25] Clinical Application of Intestinal Ultrasound in Inflammatory Bowel Disease
    Krugliak Cleveland N.
    St-Pierre J.
    Kellar A.
    Rubin D.T.
    Current Gastroenterology Reports, 2024, 26 (2) : 31 - 40
  • [26] Satisfaction with treatment amongst inflammatory bowel disease patients receiving subcutaneous biologic treatment and infused biologic treatment
    Wang, S.
    Piercy, J.
    Jakubanis, R.
    Skup, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S400 - S400
  • [27] Second-Line Biologic Therapy Persistence in a Multicentre Cohort of Inflammatory Bowel Disease Patients
    Doherty, J.
    Stack, R.
    Morain, N. O.
    Corcoran, R.
    Ryan, B.
    Doherty, G.
    Mc Namara, D.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I211 - I211
  • [28] MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease
    Cordes, Friederike
    Demmig, Claudia
    Bokemeyer, Arne
    Brueckner, Markus
    Lenze, Frank
    Lenz, Philipp
    Nowacki, Tobias
    Tepasse, Phil
    Schmidt, Hartmut H.
    Schmidt, M. Alexander
    Cichon, Christoph
    Bettenworth, Dominik
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00134
  • [29] Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease
    Petersen, Sofie Ronja
    Rasmussen, Nathalie Fogh
    Donskov, Agnete Overgaard
    Thygesen, Lau Caspar
    Olsen, Kim Rose
    Ahrenfeldt, Linda Juel
    Andersen, Vibeke
    WIENER KLINISCHE WOCHENSCHRIFT, 2024,
  • [30] Position paper on reporting of intestinal ultrasound findings in patients with inflammatory bowel disease
    Kucharzik, Torsten
    Atreya, Raja
    Bachmann, Oliver
    Baumgart, Daniel C.
    Daebritz, Jan
    Helwig, Ulf
    Janschek, Johannes
    Kienle, Peter
    Langhorst, Jost
    Mudter, Jonas
    Schmidt, Carsten
    Schreyer, Andreas G.
    Vieth, Michael
    Wessling, Johannes
    Maaser, Christian
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (06): : 978 - 990
12345